Cephrim Biosciences is a preclinical contract research organization specializing in high quality yet cost-effective pharmacological profiling of small molecule compounds and biologicals in small animal models. We offer pharmacological screening services to help identify lead compounds for future development and preclinical assessment of toxicology and safety.
Selected lead compounds can then be analyzed in more sophisticated animal disease models to establish in vivo proof-of-principle. Disease models in the areas of cancer, inflammatory diseases and neurology are currently available for efficacy testing and the analysis of biomarkers. If requested, further optimization of dosing, scheduling, and formulation can also be performed.
Cephrim Biosciences’ business model is to provide our clients in the biotech and pharmaceutical industry with access to state-of-the-art pharmacological expertise and pre-clinical testing services. Our mission is to deliver high-quality research results that can be used to assess the potential of each drug for clinical success.
We are especially committed to offer our clients a personalized approach to the design of their pharmacological studies, and we work closely with our clients when selecting the optimal animal models and study parameters to ensure that each study delivers the highest value for future decision making. We provide continuous updates for ongoing studies, and take great care to complete studies on time and within the specified budget.